Skip to main content

SpyGlass Pharma, Inc. Common Stock

SGP NASDAQ Categories PDF
Healthcare · Biotechnology
Aliso Viejo, CA 92656, United States IPO 2008 spyglasspharma.com Updated Jul 11, 2:02pm
Price
$22.52
Market Cap
$752.9M
Employees
65
Beta
-0.96
Avg Volume
96,906
CEO
Patrick H. Mooney

SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.

Runs with full report
Price Overview
Last updated: Jul 11, 2026 4:39pm (just now)
Current data · timestamped when a report runs
$22.52
Change · Jul 11
+2.45 (+12.21%)
Day Range
$19.53 – $22.92
52-Week Range
$17.06 – $32.44
50-Day MA
$20.80
200-Day MA
$23.40
Volume
167,496.00
Analyst Price Targets
Low $62.00
Consensus $62.00
High $62.00
(1 analysts)
Share Structure
Outstanding 33,433,352.00
Float 9,821,180.00
Free Float 29.4%
Low free float — 29.4% of shares trade freely, ~70.6% held by insiders/institutions
Below average liquidity. Large orders can move the price significantly. Insiders or strategic holders control the majority — watch for lockup expirations or secondary offerings.
Small absolute float (9.8M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Last updated: Jul 11, 2026 2:02pm (2h ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jul 11, 2026 2:02pm (2h ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-18.92
Stock Price: $22.52
EPS (Diluted): -1.19
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
-8.93
Stock Price: $22.52
Total Equity: -$98.84M
Shares: 33,426,557
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-19.96
Market Cap: $752.92M
Total Debt: $0.00
Cash: $96.36M
EBITDA: -$39.26M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$787.7M
Market Cap: $752.92M
Total Debt: $0.00
Cash: $96.36M
P/S Ratio (Price per dollar of revenue)
API
Stock Price / Revenue Per Share
0.00
Stock Price: $22.52
Revenue: $0.00
Shares: 33,426,557
EV/Sales (Total value vs revenue — works when P/E can't)
API
0.00
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
0.0%
Gross Profit: -$612,000
Revenue: $0.00
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
0.0%
Operating Income: -$41.45M
Revenue: $0.00
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
0.0%
Net Income: -$39.87M
Revenue: $0.00
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-123.5%
Net Income: -$39.87M
Total Equity: -$98.84M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-11.5%
Operating Income: -$41.45M
Tax Rate: 0.0%
Equity: -$98.84M
Total Debt: $0.00
Cash: $96.36M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
12.67
Current Assets: $108.77M
Current Liabilities: $8.58M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: -$98.84M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
Revenue: $0.00
Shares: 33,426,557
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$-2.96
Total Equity: -$98.84M
Shares: 33,426,557
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-1.00
Operating CF: -$32.70M
CapEx: -$789,000
Shares: 33,426,557
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $22.52
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: -$39.87M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares SGP against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)
Metric 2025
Revenue $0
Cost of Revenue $612,000
Gross Profit $-612,000
Operating Expenses $40.8M
Operating Income -$41.4M
Net Income -$39.9M
EBITDA -$39.3M
EPS $-1.19
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)
Metric 2025
Cash & Equivalents $96.4M
Total Current Assets $108.8M
Total Assets $115.9M
Current Liabilities $8.6M
Long-Term Debt $0
Total Liabilities $214.7M
Total Equity -$98.8M
Retained Earnings -$104.7M
Cash Flow (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)
Metric 2025
Operating Cash Flow -$32.7M
Capital Expenditure $-789,000
Free Cash Flow -$33.5M
Acquisitions (net) $0
Debt Repayment
Dividends Paid
Stock Buybacks -$1.5M
Net Change in Cash $80.1M
Analyst Estimates (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)
Metric 2027 2028 2029 2030
Revenue $0 $0 $16.5M
$16.5M – $16.5M
$81.8M
$81.8M – $81.8M
EBITDA $0 $0 $0 $0
Net Income -$87.0M
-$94.9M – -$84.6M
-$116.7M
-$174.3M – -$71.1M
-$113.1M
-$113.1M – -$113.1M
-$98.4M
-$98.4M – -$98.4M
EPS
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for SGP — it's generated by the pipeline (market-narrative step).
Community AI Feedback
No community reviews yet for SGP. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.406 · 9aebe10a · 2026-07-11 16:07:30